Promethium Advisors
ABBV icon

Promethium Advisors’s AbbVie ABBV Stock Holding History

Promethium Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.54M Sell
17,349
-122
-0.7% -$31.3K 2.23% 11
2026
Q2 		$4.4M Sell
17,471
-134
-0.8% -$28.8K 2.11% 11
2026
Q1 		$3.83M Hold
17,605
– – 1.98% 13
2025
Q4 		$4.02M Sell
17,605
-62
-0.4% -$14.1K 2.17% 10
2025
Q3 		$4.09M Sell
17,667
-236
-1% -$48.1K 2.35% 9
2025
Q2 		$3.32M Buy
17,903
+74
+0.4% +$13.8K 2.02% 13
2025
Q1 		$3.74M Buy
17,829
+1,050
+6% +$204K 2.39% 9
2024
Q4 		$2.98M Buy
16,779
+1,168
+7% +$215K 2.04% 11
2024
Q3 		$3.08M Buy
+15,611
New +$2.91M 2.18% 11

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Promethium Advisors's ABBV Position: Q3 2026 in Review

Promethium Advisors reduced its AbbVie (ABBV) stake by 0.7% in Q3 2026, selling an estimated $31.3K and leaving 17,349 shares worth $4.54M. The position accounts for 2.23% of the portfolio, ranked #11.

Promethium Advisors first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Promethium Advisors held 17,349 shares of AbbVie worth $4.54M as of Q3 2026.
  • Promethium Advisors sold 122 AbbVie shares in Q3 2026, an estimated $31.3K.
  • AbbVie made up 2.23% of Promethium Advisors's portfolio in Q3 2026, its #11 holding.
  • Promethium Advisors first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.